Mechanisms of action underlying virtual reality exposure treatment in spider phobia: Pivotal role of within-session fear reduction.

Exposure Specific phobia Therapy process Treatment response

Journal

Journal of anxiety disorders
ISSN: 1873-7897
Titre abrégé: J Anxiety Disord
Pays: Netherlands
ID NLM: 8710131

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 07 11 2022
revised: 07 09 2023
accepted: 12 10 2023
pubmed: 26 10 2023
medline: 26 10 2023
entrez: 25 10 2023
Statut: ppublish

Résumé

Although virtual-reality exposure treatment (VRET) for anxiety disorders is an efficient treatment option for specific phobia, mechanisms of action for immediate and sustained treatment response need to be elucidated. Towards this aim, core therapy process variables were assessed as predictors for short- and long-term VR treatment outcomes. In a bi-centric study, n = 186 patients with spider phobia completed a baseline-assessment, a one-session VRET, a post-therapy assessment, and a 6-month-follow-up assessment (ClinicalTrials.gov, ID: NCT03208400). Short- and long-term outcomes regarding self-reported symptoms in the spider phobia questionnaire (SPQ) and final patient-spider distance in the behavioral avoidance test (BAT) were predicted via logistic regression models with the corresponding baseline score, age, initial fear activation, within-session fear reduction and fear expectancy violation as predictors. To predict long-term remission status at 6-month-follow-up, dimensional short-term changes in the SPQ and BAT were additionally included. Higher within-session fear reductions predicted better treatment outcomes (long-term SPQ; short- and long-term BAT). Lower initial fear activation tended to be associated with better long-term outcomes (SPQ), while fear expectancy violation was not associated with any outcome measure. Short-term change in the SPQ predicted remission status. Findings highlight that in VRET for spider phobia, the experience of fear reduction is central for short- and long-term treatment success and should be focused by therapists.

Identifiants

pubmed: 37879242
pii: S0887-6185(23)00128-7
doi: 10.1016/j.janxdis.2023.102790
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03208400']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102790

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to declare.

Auteurs

Kati Roesmann (K)

Institute for Clinical Psychology and Psychotherapy, University of Siegen, Germany; Institute for Biomagnetism and Biosignalanalysis, University of Münster, Germany; Institute for Psychology, Unit for Clinical Psychology and Psychotherapy in Childhood and Adolescence, University of Osnabrück, Germany.

Elisabeth J Leehr (EJ)

Institute for Translational Psychiatry, University of Münster, Germany. Electronic address: leehr@uni-muenster.de.

Joscha Böhnlein (J)

Institute for Translational Psychiatry, University of Münster, Germany.

Bettina Gathmann (B)

Institute of Medical Psychology and Systems Neuroscience, University of Münster, Germany.

Martin J Herrmann (MJ)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.

Markus Junghöfer (M)

Institute for Biomagnetism and Biosignalanalysis, University of Münster, Germany; Otto-Creutzfeld Center for Cognitive and Behavioral Neuroscience, University of Münster, Germany.

Hanna Schwarzmeier (H)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.

Fabian R Seeger (FR)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany; Department of General Psychiatry, Centre for Psychosocial Medicine, University of Heidelberg, Heidelberg, Germany.

Niklas Siminski (N)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany.

Thomas Straube (T)

Institute of Medical Psychology and Systems Neuroscience, University of Münster, Germany.

Udo Dannlowski (U)

Institute for Translational Psychiatry, University of Münster, Germany.

Ulrike Lueken (U)

Department of Psychiatry, Psychosomatics, and Psychotherapy, Center for Mental Health, University Hospital of Würzburg, Germany; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.

Classifications MeSH